Zdrowie i gospodarka · 02/01/2018

FDA Releases Draft Guidance for Labeling Combined Hormonal Contraceptives

The Food and Drug Administration has made available a draft guidance for industry on labeling requirements for combined hormonal contraceptives, which include estrogen and progestin, and are used in various forms such as oral contraceptives and transdermal systems.